The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant

Journal of Clinical Microbiology

Volumn 49, Issue 2, 2011, Pages 715-717

  Simon, Philippe ^a   Holder, Benjamin P ^b   Bouhy, Xavier ^a   Abed, Yacine ^a   Beauchemin, Catherine A A ^b   Boivin, Guy ^a  

^a LAVAL UNIVERSITY   (Canada)

^b RYERSON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; PERAMIVIR; VIRUS SIALIDASE;

ARTICLE; CASE REPORT; CHILD; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS MUTANT; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; DRUG RESISTANCE, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MUTATION, MISSENSE; NEURAMINIDASE; OSELTAMIVIR; PLAQUE ASSAY; SUPPRESSION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 79951506684     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01732-10     Document Type: Article

References (21)

1. Abed, Y., and G. Boivin. 2006. Treatment of respiratory virus infections. Antiviral Res. 70:1-16. (Pubitemid 43675656)
2. Baz, M., Y. Abed, J. McDonald, and G. Boivin. 2006. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin. Infect. Dis. 43:1555-1561.
3. Baz, M., Y. Abed, P. Simon, M. E. Hamelin, and G. Boivin. 2010. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J. Infect. Dis. 201:740-745.
4. Bouvier, N. M., A. C. Lowen, and P. Palese. 2008. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J. Virol. 82:10052-10058.
5. Centers for Disease Control and Prevention. 24 August 2010, accession date. FluView - 2009-2010 influenza season week 20 ending May 22, 2010. CDC, Atlanta, GA. http://www.cdc.gov/flu/weekly/.
6. Centers for Disease Control and Prevention. 24 August 2010, accession date. FluView - 2008-2009 influenza season week 35 ending September 5, 2009. CDC, Atlanta, GA. http://www.cdc.gov/flu/weekly/weeklyarchives2008-2009/ weekly35.htm.
7. Hatakeyama, S., et al. 2005. Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J. Clin. Microbiol. 43:4139-4146.
8. Hayden, F. G., and P. Palese. 2002. Influenza virus, p. 891-920. In D. Richman, R. G. Webster, and F. G. Hayden (ed.), Clinical virology, 2nd ed. ASM Press, Washington, DC.
9. Herlocher, M. L., et al. 2004. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J. Infect. Dis. 190:1627-1630.
10. Hurt, A. C., J. K. Holien, and I. G. Barr. 2009. In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimicrob. Agents Chemother. 53:4433-4440.
11. Matrosovich, M., T. Matrosovich, W. Garten, and H.-D. Klenk. 2006. New low-viscosity overlay medium for viral plaque assays. Virol. J. 3:63.
12. Mattis, P., and S. Kimball. 2001-2010. The GIMP: GNU image manipulation program. Version 2.6.8. www.gimp.org.
13. Oker-Blom, N., et al. 1970. Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial. BMJ 3:676.
14. Okomo-Adhiambo, M., et al. 2010. Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance. Antimicrob. Agents Chemother. 54:1834-1841.
15. Potier, M., L. Mameli, M. Bélisle, L. Dallaire, and S. B. Melançon. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferylalpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
16. Rasband, W. S. 1997-2009. ImageJ. Image processing and analysis in Java, 1.42q ed. U. S. National Institutes of Health, Bethesda, MD.
17. Schirmer, P., and M. Holodniy. 2009. Oseltamivir for treatment and prophylaxis of influenza infection. Expert Opin. Drug Saf. 8:357-371.
18. Sheu, T. G., et al. 2008. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 52:3284-3292.
19. Sieuwerts, S., F. A. M. De Bok, E. Mols, W. M. De Vos, and J. E. T. Van Hylckama Vlieg. 2008. A simple and fast method for determining colony forming units. Lett. Appl. Microbiol. 47:275-278.
20. Weinstock, D. M., and G. Zuccotti. 2009. The evolution of influenza resistance and treatment. JAMA 301:1066-1069.
21. Yen, H.-L., et al. 2005. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob. Agents Chemother. 49:4075-4084.